Ekso Bionics (NASDAQ: EKSO) reported Q1 EPS of ($0.33), $0.17 worse than the analyst estimate of ($0.16). Revenue for the quarter came in at $4.1 million versus the consensus estimate of $4.8 million.

For earnings history and earnings-related data on Ekso Bionics (EKSO) click here.